Short answer: SARMs can cause hair loss, but how often is unknown: no study has measured scalp hair loss with any SARM. Male-pattern hair loss depends on androgens acting on genetically susceptible scalp follicles through the androgen receptor (Ellis 2002), and SARMs activate that same receptor, so people prone to balding are the ones most likely to notice shedding. Users most often report it with stronger compounds such as RAD-140, S23 and YK11, and less with ostarine. The old claims on this page that pure SARMs never cause hair loss and that MK-677 protects hair have no evidence behind them and have been removed.
SARMs hair loss?
How SARMs prevent hair loss
The old version of this page argued that SARMs prevent hair loss because they lower natural testosterone, and so DHT. That is a theory, not a finding. SARMs lower your own testosterone, but they activate the androgen receptor themselves, and the androgen receptor is exactly what drives pattern hair loss (Ellis 2002). Whether the net effect on scalp hair is better or worse has never been studied. The one trial that looked at hair in any way, the 86-day ostarine trial, found no effect on body-hair growth (hirsutism) or skin oil in women at up to 3 mg a day (Dalton 2011); it did not assess scalp hair.
How SARMs can cause hair loss
Three things can contribute, in order of how well supported they are:
- Androgen activity on susceptible follicles. Pattern hair loss needs a genetic predisposition plus enough androgen action (Ellis 2002); up to half of white men are affected by 50 regardless of drugs. A compound that activates the androgen receptor can speed up what genetics would do anyway.
- Mislabeled products. Products sold as SARMs often contain other drugs or wrong amounts: only 52% of 44 tested products contained a SARM and 39% contained another unapproved drug (Van Wagoner 2017). Undeclared steroids have been found in some (Chong 2024).
- Stress and shedding. Users commonly report temporary shedding that stops after a cycle; the old page put most of it down to stress. That is plausible but not studied.
The old advice that buying “pure” SARMs removes all risk of hair loss has been removed: a pure SARM still acts on the androgen receptor.
Which SARMs cause hair loss?
No SARM has been studied for scalp hair loss, so the list below is based on how strongly each compound acts on androgen pathways and on user reports. “Lower risk” means fewer reports, not proven safety.
| Compound | User reports of hair loss | Relevant evidence |
|---|---|---|
| Ostarine | Few | No effect on women’s body hair in the 86-day trial |
| Andarine (S4) | Few | Rat data only |
| LGD-4033 | Some | Lowered testosterone at 0.1–1 mg/day; hair not studied |
| RAD-140 | Common | Strong androgen activity in animals; hair not studied |
| S23, YK11 | Common | Strong androgen-receptor activity in lab and rat studies |
| MK-677, cardarine, SR9009 | Occasional | Not SARMs; don’t act on the androgen receptor; hair not studied |
Ostarine – MK2866
Ostarine is the most studied SARM and gets the fewest hair-loss reports. In its 86-day trial at up to 3 mg a day, it did not change body-hair growth or skin oil in women (Dalton 2011), but scalp hair in men was not assessed, and user doses are far higher. “You definitely won’t lose your hair” was not a supported claim.
LGD 4033
Some users report shedding on LGD-4033. We know of no data behind the “1–2%” figure in the old version. LGD-4033 is strongly androgenic even at 1 mg a day, judging by how much it lowered testosterone and SHBG in its trial (Basaria 2013), so people prone to balding should expect some risk.
MK677 – Ibutamoren
MK-677 (ibutamoren) is a growth hormone secretagogue, not a SARM, and does not act on the androgen receptor. Claims that it improves hair or prevents hair loss are popular but have no trial evidence; hair was not an outcome in its trials. See the MK-677 fact sheet.
Cardarine – GW50156
Cardarine (GW501516) is not a SARM and does not act on the androgen receptor, so it would not be expected to cause androgen-driven hair loss. Hair was not studied in its trials, and “100% no worry” is not something any study supports. Its bigger issue is the animal cancer data; see the cardarine fact sheet.
RAD 140 – Testolone
Hair shedding is one of the most common user complaints with RAD-140. The old claim that it “doesn’t cause hair loss at all” and that stress is to blame has no evidence. RAD-140 has strong androgen activity in animals (Miller 2011), and hair was not studied in its only human trial.
YK11
YK11 is a steroidal androgen-receptor agonist with no human studies. Users report hair shedding, often recovering after the cycle (anecdotal). There is no basis for the old claim that it won’t cause hair loss “when taken correctly”. More in the YK11 review.
S4 – Andarine
Andarine (S4) gets relatively few hair-loss reports. In castrated rats it had much less effect than DHT on the prostate, a DHT-sensitive tissue (Gao 2005), but scalp hair has not been studied.
SR9009 – Stenabolic
Stenabolic (SR9009) is a REV-ERB agonist, not a SARM. It doesn’t act on the androgen receptor, so androgen-driven hair loss would not be expected, but its effect on testosterone has never been measured and it has never been tested in people.
S23
S-23 is a very potent androgen-receptor agonist in lab tests and strongly suppressed LH in rats (Jones 2009). Users rate it among the least hair-friendly SARMs (anecdotal). The old claim that “real” S23 causes no hair loss had no support.
Video Format
If you prefer video, this one covers the topic from a user’s perspective. Note that it reflects the older view on this page, that pure SARMs don’t cause hair loss, which the evidence above doesn’t support.
How to prevent hair loss on a SARM cycle
There is no proven way to prevent hair loss while taking SARMs. What can be said:
- Know your risk. If male-pattern baldness runs in your family or you are already thinning, androgen-receptor drugs carry more risk for you (Ellis 2002).
- Stronger compounds, more reports. Users report hair loss most with RAD-140, S23 and YK11, and least with ostarine.
- Hair-loss treatments. Finasteride and minoxidil are the treatments with the strongest evidence for pattern hair loss (Ellis 2002); they are prescription or pharmacy medicines and their use alongside SARMs has not been studied, so talk to a doctor.
- MK-677 is not a hair treatment. The old advice to run MK-677 to protect your hair had no evidence and has been removed.
- Quality. Undeclared steroids in mislabeled products can add androgen exposure; if you buy, use a seller with batch lab reports (our current pick is in the SwissChems review).
Will hair grow back after taking SARMs?

Users commonly report that shedding during a cycle stops and hair recovers within a few months after stopping (anecdotal; this section was merged from our older article “Which SARMs Cause Hair Loss?”). No study has followed hair after SARM use. Pattern hair loss that would have happened anyway, and was only sped up, may not fully reverse. If shedding continues months after stopping, see a doctor or dermatologist.
Conclusion
Can SARMs cause hair loss? Yes, they can: they act on the same androgen receptor that drives pattern baldness, and users report it most with RAD-140, S23 and YK11. How common it is, and whether it always reverses, has never been studied. Ostarine gets the fewest reports and showed no effect on women’s body hair in its trial. MK-677, cardarine and SR9009 are not SARMs and don’t act on the androgen receptor, but none has been shown to protect hair. Compare compounds in the SARMs database.
Frequently asked questions
Do SARMs cause hair loss?
They can; how often is unknownEvidence: User reports
SARMs activate the androgen receptor, which drives male-pattern hair loss in genetically susceptible people. No study has measured how often it happens; users report it most with stronger compounds.
Which SARMs are hair safe?
None shown to beEvidence: User reports
Ostarine and andarine get the fewest user reports. Ostarine did not affect body-hair growth in women in its 86-day trial, but scalp hair was not assessed.
Does RAD-140 cause hair loss?
Commonly reportedEvidence: User reports
Hair shedding is one of the most common user complaints with RAD-140. Hair was not studied in its only human trial, but it has strong androgen activity in animals.
Does MK-677 cause or prevent hair loss?
Neither shownEvidence: Limited
MK-677 is not a SARM and does not act on the androgen receptor. Hair was not an outcome in its trials, so neither hair loss nor hair growth has been shown.
Is SARMs hair loss permanent?
Unknown; often recovers per usersEvidence: User reports
Users usually report shedding stopping and hair recovering within months of stopping, but no study has followed it. Pattern hair loss that was only sped up may not fully reverse.
Can SARMs prevent hair loss?
Not shownEvidence: Limited
The idea rests on SARMs lowering natural testosterone, but they activate the androgen receptor themselves. It has never been tested.
Does YK11 cause hair loss?
Users report it; risk unknownEvidence: User reports
Users report hair shedding on YK11. It is a steroidal androgen-receptor agonist that has never been studied in humans.
Sources
- Androgenetic alopecia: pathogenesis and potential for therapy
- The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial
- Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet
- Reversible Gynecomastia and Hypogonadism Due to Usage of Commercial Performance-Enhancing Supplement Use
- The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men
- Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor Modulator (SARM) RAD140
- Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats
- Preclinical characterization of a (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide: a selective androgen receptor modulator for hormonal male contraception